Davita-Turfway Pd Training in Florence, Kentucky - Dialysis Center

Davita-Turfway Pd Training is a medicare approved dialysis facility center in Florence, Kentucky and it has 4 dialysis stations. It is located in Boone county at 11 Spiral Drive, Suite 15a, Florence, KY, 41042. You can reach out to the office of Davita-Turfway Pd Training at (859) 647-2802. This dialysis clinic is managed and/or owned by Davita. Davita-Turfway Pd Training has the following ownership type - Profit. It was first certified by medicare in August, 2007. The medicare id for this facility is 182586 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameDavita-Turfway Pd Training
Location11 Spiral Drive, Suite 15a, Florence, Kentucky
No. of Dialysis Stations 4
Medicare ID182586
Managed ByDavita
Ownership TypeProfit
Late Shifts No

Contact Information


11 Spiral Drive, Suite 15a, Florence, Kentucky, 41042
(859) 647-2802

News Archive

Discovery of two novel gene locations that raise risk of type 1 diabetes

Genetics researchers have identified two novel gene locations that raise the risk of type 1 diabetes. As they continue to reveal pieces of the complicated genetic puzzle for this disease, the researchers expect to improve predictive tests and devise preventive strategies.

Four Rivers Software offers Data Entry Services for healthcare industry

Four Rivers Software, a leading computerized maintenance management software (CMMS) provider for the healthcare industry announces Data Entry Services. These services are the latest addition to its overall Data Services Offerings.

Study: Stretching before running neither prevents nor causes injury

Stretching before a run neither prevents nor causes injury, according to a study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

NeoPharm, Inc., announced today that it has filed an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) for IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is the most deadly disease of the lungs in humans with very high morbidity. There is currently no proven effective treatment for the cure of this disease.

Disabling gene defuses rheumatoid arthritis in mice

Scientists studying mice have identified a gene that allows immune cells known as neutrophils to protect themselves from the inflammatory chemicals they secrete.

Read more Medical News

› Verified 4 days ago


Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Davita-Turfway Pd Training from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1225249626
Organization NameTurfway Pd Training
Doing Business AsOhio River Dialysis Llc
Address11 Spiral Dr Ste 15a Florence, Kentucky, 41042
Phone Number(859) 647-2802

News Archive

Discovery of two novel gene locations that raise risk of type 1 diabetes

Genetics researchers have identified two novel gene locations that raise the risk of type 1 diabetes. As they continue to reveal pieces of the complicated genetic puzzle for this disease, the researchers expect to improve predictive tests and devise preventive strategies.

Four Rivers Software offers Data Entry Services for healthcare industry

Four Rivers Software, a leading computerized maintenance management software (CMMS) provider for the healthcare industry announces Data Entry Services. These services are the latest addition to its overall Data Services Offerings.

Study: Stretching before running neither prevents nor causes injury

Stretching before a run neither prevents nor causes injury, according to a study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

NeoPharm, Inc., announced today that it has filed an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) for IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is the most deadly disease of the lungs in humans with very high morbidity. There is currently no proven effective treatment for the cure of this disease.

Disabling gene defuses rheumatoid arthritis in mice

Scientists studying mice have identified a gene that allows immune cells known as neutrophils to protect themselves from the inflammatory chemicals they secrete.

Read more Medical News

› Verified 4 days ago


Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data30
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL27

News Archive

Discovery of two novel gene locations that raise risk of type 1 diabetes

Genetics researchers have identified two novel gene locations that raise the risk of type 1 diabetes. As they continue to reveal pieces of the complicated genetic puzzle for this disease, the researchers expect to improve predictive tests and devise preventive strategies.

Four Rivers Software offers Data Entry Services for healthcare industry

Four Rivers Software, a leading computerized maintenance management software (CMMS) provider for the healthcare industry announces Data Entry Services. These services are the latest addition to its overall Data Services Offerings.

Study: Stretching before running neither prevents nor causes injury

Stretching before a run neither prevents nor causes injury, according to a study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

NeoPharm, Inc., announced today that it has filed an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) for IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is the most deadly disease of the lungs in humans with very high morbidity. There is currently no proven effective treatment for the cure of this disease.

Disabling gene defuses rheumatoid arthritis in mice

Scientists studying mice have identified a gene that allows immune cells known as neutrophils to protect themselves from the inflammatory chemicals they secrete.

Read more Medical News

› Verified 4 days ago

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center1
    Adult patient months included in Kt/V greater than or equal to 1.27
    Percentage of adult patients getting regular hemodialysis at the center
    Percentage of pediatric patients getting regular hemodialysis at the center

    News Archive

    Discovery of two novel gene locations that raise risk of type 1 diabetes

    Genetics researchers have identified two novel gene locations that raise the risk of type 1 diabetes. As they continue to reveal pieces of the complicated genetic puzzle for this disease, the researchers expect to improve predictive tests and devise preventive strategies.

    Four Rivers Software offers Data Entry Services for healthcare industry

    Four Rivers Software, a leading computerized maintenance management software (CMMS) provider for the healthcare industry announces Data Entry Services. These services are the latest addition to its overall Data Services Offerings.

    Study: Stretching before running neither prevents nor causes injury

    Stretching before a run neither prevents nor causes injury, according to a study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.

    NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

    NeoPharm, Inc., announced today that it has filed an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) for IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is the most deadly disease of the lungs in humans with very high morbidity. There is currently no proven effective treatment for the cure of this disease.

    Disabling gene defuses rheumatoid arthritis in mice

    Scientists studying mice have identified a gene that allows immune cells known as neutrophils to protect themselves from the inflammatory chemicals they secrete.

    Read more Medical News

    › Verified 4 days ago

  • Peritoneal Dialysis
    Adult patients getting regular peritoneal dialysis at the center86
    Adult patient months included in Kt/V greater than or equal to 1.7697
    Percentage of adult patients getting regular peritoneal dialysis at the center98
    Percentage of pediatric patients getting regular peritoneal dialysis at the center

    News Archive

    Discovery of two novel gene locations that raise risk of type 1 diabetes

    Genetics researchers have identified two novel gene locations that raise the risk of type 1 diabetes. As they continue to reveal pieces of the complicated genetic puzzle for this disease, the researchers expect to improve predictive tests and devise preventive strategies.

    Four Rivers Software offers Data Entry Services for healthcare industry

    Four Rivers Software, a leading computerized maintenance management software (CMMS) provider for the healthcare industry announces Data Entry Services. These services are the latest addition to its overall Data Services Offerings.

    Study: Stretching before running neither prevents nor causes injury

    Stretching before a run neither prevents nor causes injury, according to a study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.

    NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

    NeoPharm, Inc., announced today that it has filed an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) for IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is the most deadly disease of the lungs in humans with very high morbidity. There is currently no proven effective treatment for the cure of this disease.

    Disabling gene defuses rheumatoid arthritis in mice

    Scientists studying mice have identified a gene that allows immune cells known as neutrophils to protect themselves from the inflammatory chemicals they secrete.

    Read more Medical News

    › Verified 4 days ago

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Davita-Turfway Pd Training with elevated calcium levels.

Patients with hypercalcemia102
Hypercalcemia patient months821
Hypercalcemia patients with serumcalcium greater than 10.2 mg1
Patients with Serumphosphor106
Patients with Serumphosphor less than 3.5 mg/dL11
Patients with Serumphosphor from 3.5 to 4.5 mg/dL30
Patients with Serumphosphor from 4.6 to 5.5 mg/dL28
Patients with Serumphosphor from 5.6 to 7 mg/dL21
Patients with Serumphosphor greater than 7 mg/dL10

News Archive

Discovery of two novel gene locations that raise risk of type 1 diabetes

Genetics researchers have identified two novel gene locations that raise the risk of type 1 diabetes. As they continue to reveal pieces of the complicated genetic puzzle for this disease, the researchers expect to improve predictive tests and devise preventive strategies.

Four Rivers Software offers Data Entry Services for healthcare industry

Four Rivers Software, a leading computerized maintenance management software (CMMS) provider for the healthcare industry announces Data Entry Services. These services are the latest addition to its overall Data Services Offerings.

Study: Stretching before running neither prevents nor causes injury

Stretching before a run neither prevents nor causes injury, according to a study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

NeoPharm, Inc., announced today that it has filed an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) for IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is the most deadly disease of the lungs in humans with very high morbidity. There is currently no proven effective treatment for the cure of this disease.

Disabling gene defuses rheumatoid arthritis in mice

Scientists studying mice have identified a gene that allows immune cells known as neutrophils to protect themselves from the inflammatory chemicals they secrete.

Read more Medical News

› Verified 4 days ago

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 11
Patient months included in arterial venous fistula and catheter summaries 77
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment71
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer13

News Archive

Discovery of two novel gene locations that raise risk of type 1 diabetes

Genetics researchers have identified two novel gene locations that raise the risk of type 1 diabetes. As they continue to reveal pieces of the complicated genetic puzzle for this disease, the researchers expect to improve predictive tests and devise preventive strategies.

Four Rivers Software offers Data Entry Services for healthcare industry

Four Rivers Software, a leading computerized maintenance management software (CMMS) provider for the healthcare industry announces Data Entry Services. These services are the latest addition to its overall Data Services Offerings.

Study: Stretching before running neither prevents nor causes injury

Stretching before a run neither prevents nor causes injury, according to a study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

NeoPharm, Inc., announced today that it has filed an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) for IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is the most deadly disease of the lungs in humans with very high morbidity. There is currently no proven effective treatment for the cure of this disease.

Disabling gene defuses rheumatoid arthritis in mice

Scientists studying mice have identified a gene that allows immune cells known as neutrophils to protect themselves from the inflammatory chemicals they secrete.

Read more Medical News

› Verified 4 days ago

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary78
Hospitalization Rate in facility229.7 (As Expected)
Hospitalization Rate: Upper Confidence Limit375.3
Hospitalization Rate: Lower Confidence Limit144.4

News Archive

Discovery of two novel gene locations that raise risk of type 1 diabetes

Genetics researchers have identified two novel gene locations that raise the risk of type 1 diabetes. As they continue to reveal pieces of the complicated genetic puzzle for this disease, the researchers expect to improve predictive tests and devise preventive strategies.

Four Rivers Software offers Data Entry Services for healthcare industry

Four Rivers Software, a leading computerized maintenance management software (CMMS) provider for the healthcare industry announces Data Entry Services. These services are the latest addition to its overall Data Services Offerings.

Study: Stretching before running neither prevents nor causes injury

Stretching before a run neither prevents nor causes injury, according to a study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

NeoPharm, Inc., announced today that it has filed an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) for IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is the most deadly disease of the lungs in humans with very high morbidity. There is currently no proven effective treatment for the cure of this disease.

Disabling gene defuses rheumatoid arthritis in mice

Scientists studying mice have identified a gene that allows immune cells known as neutrophils to protect themselves from the inflammatory chemicals they secrete.

Read more Medical News

› Verified 4 days ago

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Davita-Turfway Pd Training were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility26.8 (As Expected)
Readmission Rate: Upper Confidence Limit41.7
Readmission Rate: Lower Confidence Limit15.2

News Archive

Discovery of two novel gene locations that raise risk of type 1 diabetes

Genetics researchers have identified two novel gene locations that raise the risk of type 1 diabetes. As they continue to reveal pieces of the complicated genetic puzzle for this disease, the researchers expect to improve predictive tests and devise preventive strategies.

Four Rivers Software offers Data Entry Services for healthcare industry

Four Rivers Software, a leading computerized maintenance management software (CMMS) provider for the healthcare industry announces Data Entry Services. These services are the latest addition to its overall Data Services Offerings.

Study: Stretching before running neither prevents nor causes injury

Stretching before a run neither prevents nor causes injury, according to a study presented today at the 2011 Annual Meeting of the American Academy of Orthopaedic Surgeons.

NeoPharm submits IL13-PE38QQR IND for the treatment of IPF

NeoPharm, Inc., announced today that it has filed an investigational new drug application (IND) with the U.S. Food and Drug Administration (FDA) for IL13-PE38QQR (IL13-PE) for the treatment of Idiopathic Pulmonary Fibrosis (IPF). IPF is the most deadly disease of the lungs in humans with very high morbidity. There is currently no proven effective treatment for the cure of this disease.

Disabling gene defuses rheumatoid arthritis in mice

Scientists studying mice have identified a gene that allows immune cells known as neutrophils to protect themselves from the inflammatory chemicals they secrete.

Read more Medical News

› Verified 4 days ago